Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993)
Main Author: | Andreas Bohle |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Urologia
2011-04-01
|
Series: | International Brazilian Journal of Urology |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382011000200024 |
Similar Items
-
Long-term efficacy results of EORTC Genito-Urinary Group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder
by: Andreas Bohle
Published: (2010-08-01) -
Intravesical Bacillus Calmette-Guerin for Treatment of Refractory Interstitial Cystitis
by: Saeed Arasteh, et al.
Published: (2007-02-01) -
Tuberculous prostatic abscess following intravesical bacillus Calmette-Guérin immunotherapy
by: Bin Wang, et al.
Published: (2019-09-01) -
Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
by: Centola Michael, et al.
Published: (2007-05-01) -
Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder Cancer
by: Masashi Miyazaki, et al.
Published: (2016-01-01)